Table: Oncolys Biopharma - 9-MTH parent results

Oncolys Biopharma

02/11/2017 06:00

Nov 2 (Reuters)-  
             Oncolys Biopharma Inc.  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended        Year to    
                Sep 30, 2017        Sep 30, 2016       Dec 31, 2017   
                   LATEST             YEAR-AGO            LATEST      
                   RESULTS             RESULTS           FORECAST     
  Sales            29 mln              46 mln            200 mln      
                 (-37.6 pct)        (+133.5 pct)       (+112.4 pct)   
  Operating     loss 768 mln        loss 679 mln        loss 1.40     
  Recurring     loss 776 mln        loss 682 mln        loss 1.40     
  Net           loss 779 mln        loss 731 mln        loss 1.40     
  EPS          loss 77.81 yen      loss 79.53 yen    loss 152.08 yen  
  Ann Div                                NIL               NIL        
  -Q2 div            NIL                 NIL                          
  -Q4 div                                NIL               NIL        
   
  NOTE - Oncolys Biopharma Inc..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T  
  ((Tokyo Headline News Desk +813 6441 1812))